+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 100Years
All Genders
ID07309029

Evaluating Pre-emptive Left Atrial Veno-Arterial ECMO Support During Complex High-Risk Transcatheter Aortic Valve Replacement

Led by Atlantic Health System · Updated on 2025-12-30

30

Participants Needed

2

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of pre-emptive left atrial veno-arterial extracorporeal membrane oxygenation LAVA-ECMO in adults undergoing complex and high-risk transcatheter aortic valve replacement TAVR. This study focuses on patients with severe aortic stenosis who are either hemodynamically unstable or at risk of instability due to anatomical complexity. The trial aims to determine if LAVA-ECMO can reduce the risk of in-hospital death, cardiac arrest during the procedure, or emergency cardiac surgery, as well as assess safety outcomes related to major vascular, bleeding, or cardiac complications.

CONDITIONS

Brief Title

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

Research Team

G

Gennaro Giustino, MD

P

Pedro Villablanca, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here